Abstract: An electric compressor and a refrigeration device having the same are provided. The electric compressor includes: an electric motor having a stator and a rotor; a compressing mechanism having an eccentric shaft rotatably and slidably connected to the rotor and defining a compressing chamber therein, the compressing chamber being configured to perform a compression by the eccentric shaft; and a torque damping device configured to connect the rotor with the eccentric shaft, in which during the compression of the compressing chamber, a difference between a rotation angle of the eccentric shaft and a rotation angle of the rotor is a phase angle which is increased and decreased.

Abstract: A refrigeration cycle device and a two-stage rotary compressor thereof. The two-stage rotary compressor includes a housing with a gas injection chamber and two cylinders disposed therein; the gas injection chamber connected to a liquid reservoir disposed outside of the housing and a gas injection pipe; a first cylinder in communication with the gas injection chamber; a second cylinder connected to the liquid reservoir, and having a sliding vane groove and a compression chamber with a piston disposed therein in communication with the gas injection chamber; a sliding vane, received in the sliding vane groove when the gas injection chamber is in communication with the liquid reservoir, with an outer end and the sliding vane groove defining a backpressure chamber in communication with the gas injection chamber; and with an inner end abutting against the piston when the gas injection chamber is in communication with the gas injection pipe.

Abstract: A method for suppressing a speed fluctuation of a permanent magnet synchronous motor is provided in the present disclosure, including: obtaining a target speed ?_ref, a feedback speed, a fluctuation speed ??, a q-axis inductance Lq and a permanent magnet flux linkage ?f of the permanent magnet synchronous motor; performing a PI adjusting on ?? to obtain a q-axis reference current Iq_ref, and obtaining a q-axis target voltage U*q according to Iq_ref, ?_ref, ?? and ?f; performing a PI control on a q-axis actual voltage according to U*q to obtain a q-axis compensation current Iq_add; obtaining a d-axis target voltage U*d according to Iq_ref, Iq_add, ?_ref, ?? and Lq; performing a PI control on a d-axis actual voltage according to U*d to obtain a d-axis compensation current Id_add; superposing Iq_add and Iq_ref to perform a feedforward compensation on a q-axis current and superposing Id_add and the d-axis reference current to perform a feedforward compensation on a d-axis current.

Abstract: This invention discloses bioerodible delivery compositions for delivering peptide therapeutic agents. The delivery compositions comprise a porous silicon-based carrier material loaded with the therapeutic agent. The delivery compositions may be used in vitro or in vivo to deliver the therapeutic agent, preferably in a controlled fashion over an intended period of time such as over multiple days, weeks or months. The delivery compositions may be used for treating or preventing conditions of a patient such as chronic diseases.

Abstract: The invention provides a biodegradable drug-eluting particle useful for the delivery of diagnostic or therapeutic agents. In certain embodiments, the drug-eluting particle of the invention comprises a biodegradable porous silicon body, a reservoir formed within the porous silicon body having at least one opening to an exterior of the body, wherein the reservoir contains a therapeutic or diagnostic agent, and an agent-permeable seal disposed over the at least one opening. The invention further provides a method for treating a patient to obtain a desired local or systemic physiological or pharmacological effect comprising administering a sustained release drug delivery particle of the invention. The invention also provides methods of fabricating a drug-eluting particle for releasing therapeutic agents.

Abstract: A compression device includes an air cylinder (31); an upper bearing (4) and a lower bearing (5); a piston (71) which defines a working space; a first slide vane (81) and a second slide vane (82) which separate the working space into a first and a second working chamber; a first air suction port (101) and a second air suction port (102) both of which are in communication with the working space; and a first air discharge port (91) and a second air discharge port (92) both of which are in communication with the working space. The first and the second air suction port satisfy the following condition: 0.25?(V1/S1)*(S2/V2)?4, where V1 and V2 are respectively the maximum volume of the first and the second working chamber, and S1 and S2 are respectively the opening area of the first and the second air suction port.

Abstract: A method for suppressing a speed fluctuation of a permanent magnet synchronous motor is provided in the present disclosure, including: obtaining a target speed ?—ref, a feedback speed, a fluctuation speed ??, a q-axis inductance Lq and a permanent magnet flux linkage ?f of the permanent magnet synchronous motor; performing a PI adjusting on ?? to obtain a q-axis reference current Iq_ref, and obtaining a q-axis target voltage U*q according to Iq_ref, ?—ref, ?? and ?f; performing a PI control on a q-axis actual voltage according to U*q to obtain a q-axis compensation current Iq_add; obtaining a d-axis target voltage U*d according to Iq_ref, Iq_add, ?—ref, ?? and Lq; performing a PI control on a d-axis actual voltage according to U*d to obtain a d-axis compensation current Id_add; superposing Iq_add and Iq_ref to perform a feedforward compensation on a q-axis current and superposing Id_add and the d-axis reference current to perform a feedforward compensation on a d-axis current.

Abstract: A rotatory compressor and a refrigerating cycle device are provided. The rotatory compressor includes a lubricating oil in an interior of a hermetically sealed housing, and an electric motor and a rotatory compressing mechanism disposed in the housing. An internal pressure of the housing is substantially equal to a suction pressure of the compressing mechanism. The compressing mechanism includes a first bearing and a second bearing at least one of which includes an exhaust muffler. A refrigerant of the exhaust muffler flows through the sliding vane chamber and is discharged from an exhaust pipe of the compressing mechanism.

Abstract: A refrigerant filling rotary compressor includes a shell, a compressing mechanism, an injection tube and an injection valve assembly. The compressing mechanism includes a cylinder, a main bearing, an auxiliary bearing, a crank shaft, a piston and a sliding vane. An inner wall of the cylinder chamber of the cylinder is formed with a filling mouth, and the cylinder is provided with a filling channel with a filling hole.

Abstract: This invention discloses reservoirs, such as implants for delivering therapeutic agents, particularly large molecules such as proteins and antibodies. The reservoirs may comprise a porous silicon-based carrier material impregnated with the therapeutic agent. The reservoir may be used in vitro or in vivo to maintain an equilibrium concentration of a therapeutic agent over an intended period of time such as over multiple days, weeks, months, or years. Additionally, the reservoir may be reloaded with additional therapeutic agent. These reservoirs may be used for treating or preventing conditions of a subject such as chronic diseases.

Abstract: An electric machine has a stator and a rotor. The stator has a housing and at least one pair of magnetic poles. Each magnetic pole has a primary magnet and two auxiliary magnets disposed on respective sides of the primary magnet. All of the magnets are disposed on an inner surface of the housing. All the magnets of a magnetic pole have the same polarity.

Abstract: A method and device for treating a mammalian organism to obtain a desired local or systemic physiological or pharmacological effect is provided. The method includes administering a sustained release drug delivery system to a mammalian organism in need of such treatment at an area wherein release of an effective agent is desired and allowing the effective agent to pass through the device in a controlled manner. The device includes an inner core or reservoir including the effective agent, an impermeable tube which encloses portions of the reservoir, and a permeable member at an end of the tube.

Abstract: A method and device for treating a mammalian organism to obtain a desired local or systemic physiological or pharmacological effect is provided. The method includes administering a sustained release drug delivery system to a mammalian organism in need of such treatment at an area wherein release of an effective agent is desired and allowing the effective agent to pass through the device in a controlled manner. The device includes an inner core or reservoir including the effective agent, an impermeable tube which encloses portions of the reservoir, and a permeable member at an end of the tube.

Abstract: The invention provides a biodegradable drug-eluting particle useful for the delivery of diagnostic or therapeutic agents. In certain embodiments, the drug-eluting particle of the invention comprises a biodegradable porous silicon body, a reservoir formed within the porous silicon body having at least one opening to an exterior of the body, wherein the reservoir contains a therapeutic or diagnostic agent, and an agent-permeable seal disposed over the at least one opening. The invention further provides a method for treating a patient to obtain a desired local or systemic physiological or pharmacological effect comprising administering a sustained release drug delivery particle of the invention.

Abstract: An automatic aligning apparatus for aligning aligning components of a first object with aligning components of a second object includes first and second aligning mechanisms. The first aligning mechanism carries the first object and has a guiding groove. The second aligning mechanism has a carrying component that carries the second object, two rear holding plates, and two connecting components, each extending through a through hole in a corresponding rear holding plate and having two clamping parts that clamp a corresponding rear holding plate. The carrying component is movable between an initial position and an aligning position where a guiding stud of the carrying component extends into the guiding groove.

Abstract: Embodiments of intrinsic magneto-thermoelectric transport in MTJs carrying a tunneling current/in the absence of external heat sources are presented. In one embodiment Ohm's law for describing MTJs may be revised even in the linear transport regime. This has a profound impact on the dynamic response of MTJs subject to an ac electric bias with frequency ?, as demonstrated by a novel Seebeck rectification effect measured for ? up to microwave (GHz) frequencies. This Seebeck rectification effect may be employed in magneto-thermoelectric devices.

Abstract: The invention provides a biodegradable drug-eluting particle useful for the delivery of diagnostic or therapeutic agents. In certain embodiments, the drug-eluting particle of the invention comprises a biodegradable porous silicon body, a reservoir formed within the porous silicon body having at least one opening to an exterior of the body, wherein the reservoir contains a therapeutic or diagnostic agent, and an agent-permeable seal disposed over the at least one opening. The invention further provides a method for treating a patient to obtain a desired local or systemic physiological or pharmacological effect comprising administering a sustained release drug delivery particle of the invention. The invention also provides methods of fabricating a drug-eluting particle for releasing therapeutic agents.

Abstract: The present invention relates to sustained release drug delivery systems, medical devices incorporating said systems, and methods of use and manufacture thereof. The inventive systems feature bioerodible drug delivery devices that include biocompatible solid and biocompatible fluid compositions to achieve desired sustained release drug delivery.

Abstract: Systems and methods for associating geographic coordinates with one or more points in a digital geographic image, such as a satellite image, aerial image, ground based image, street level image or other suitable geographic image are provided. More particularly, a digital geographic image can be analyzed to identify one or more features that may be suitable as measurement points for collecting measured ground truth data. The one or more features can be described as a mathematical model that defines image coordinates along the feature depicted in the digital geographic image with sub-pixel accuracy. Image coordinates can be assigned to the measurement points with sub-pixel accuracy using the mathematical model. Collected ground truth data can then be associated with the identified image coordinates to allow for the more precise association of geographic coordinate information to points in the digital geographic imagery.

Abstract: An injectable drug delivery device includes a core containing one or more drugs and one or more polymers. The core may be surrounded by one or more polymer outer layers (referred to herein as “coatings,” “skins,” or “outer layers”). In certain embodiments, the device is formed by extruding or otherwise preforming a polymeric skin for a drug core. The drug core may be co-extruded with the skin, or inserted into the skin after the skin has been extruded, and possibly cured. In other embodiments, the drug core may be coated with one or more polymer coatings. These techniques may be usefully applied to fabricate devices having a wide array of drug formulations and skins that can be selected to control the release rate profile and various other properties of the drugs in the drug core in a form suitable for injection using standard or non-standard gauge needles.